Clinical Trial Update: the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of a 5-HT3 receptor antagonist, dexamethasone, or dispersible tablets of megestrol acetate for control…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Tumor

Drugs mentioned

• 5-HT3 receptor antagonist (5-HT3 receptor antagonist)
• DEXAMETHASONE (Dexamethasone)
• Megestrol Acetate Dispersible Tablets (megestrol acetate)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Tumor, Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: UNKNOWN